Edgestream Partners, L.P.

Position in VTRS — Viatris Inc

CIK 1535061 Princeton, NJ

Position in VTRS

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$4,448,518

+$131,495 QoQ

Shares Held

329,276

-24.5% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Edgestream Partners, L.P. holds $28,592,165 across 5 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (15.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	77,506	$9,161,984
2	NBIX	Neurocrine Biosciences Inc	50,587	$6,664,331
3	PBH	Prestige Consumer Healthcare Inc.	108,814	$6,449,405
4	VTRS	Viatris Inc This page	329,276	$4,448,518
5	ALKS	Alkermes plc.	52,826	$1,867,927

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,448,518	329,276	-24.5%	Shares	Sole	2026-05-18
2025-09-30	$4,317,023	436,063	+762.7%	Shares	Sole	2025-11-12
2025-06-30	$451,393	50,548	-69.0%	Shares	Sole	2025-08-13
2024-12-31	$2,032,387	163,244	-65.4%	Shares	Sole	2025-02-07
2024-09-30	$5,478,515	471,879	+946.6%	Shares	Sole	2024-11-14
2024-06-30	$479,274	45,087	-22.1%	Shares	Sole	2024-08-09
2024-03-31	$690,884	57,863	-70.9%	Shares	Sole	2024-05-10
2023-09-30	$1,960,572	198,841	+456.2%	Shares	Sole	2023-11-15
2023-03-31	$343,886	35,747	-30.6%	Shares	Sole	2023-05-15
2022-03-31	$560,570	51,523	—	Shares	Sole	2022-05-13
No filing history on record for this holder in this stock.